Professor Mikaël Pittet, holder of the ISREC Foundation Chair in Onco-Immunology at the University of Geneva, Ludwig Institute member, and AGORA member, recently participated in the RTS podcast Le régime cétogène et ses capacités à lutter contre certaines maladies (in French).
In this episode, Professor Pittet discusses a recent study examining the potential of the ketogenic diet in enhancing cancer treatments. He also provides expert insights into CAR-T cell therapy, an advanced immunotherapy that genetically modifies T cells to more effectively target and attack cancer cells.
For additional information, here are two key supporting studies:
American Hematology Congress Study
Link to the full episode:
Le régime cétogène et ses capacités à lutter contre certaines maladies – RTS Podcast
Professor Pittet’s research focuses on harnessing the immune system to fight cancer, particularly through the development of innovative immunotherapies. His work explores the interactions between immune cells and tumors, with a focus on how these interactions can be leveraged to improve treatment outcomes.
